Genetic Signatures (Australia) Insiders

Genetic Signatures Management Team Effectiveness

The company has return on total asset (ROA) of (0.15) % which means that it has lost $0.15 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3616) %, meaning that it generated substantial loss on money invested by shareholders. Genetic Signatures' management efficiency ratios could be used to measure how well Genetic Signatures manages its routine affairs as well as how well it operates its assets and liabilities. Total Current Liabilities is likely to drop to about 2.9 M in 2025. Liabilities And Stockholders Equity is likely to drop to about 34.7 M in 2025Common Stock Shares Outstanding is likely to drop to about 126.3 M in 2025. Net Loss is likely to gain to about (19.1 M) in 2025

Genetic Signatures Workforce Comparison

The company has Profit Margin (PM) of (1.02) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.48) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.48.

Genetic Signatures Benchmark Summation

Genetic Signatures Notable Stakeholders

The success or failure of an entity such as Genetic Signatures often depends on how effective the management is. Genetic Signatures management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Genetic management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Genetic management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Genetic Signatures' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Genetic Signatures. Check Genetic Signatures' Beneish M Score to see the likelihood of Genetic Signatures' management manipulating its earnings.

When running Genetic Signatures' price analysis, check to measure Genetic Signatures' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genetic Signatures is operating at the current time. Most of Genetic Signatures' value examination focuses on studying past and present price action to predict the probability of Genetic Signatures' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genetic Signatures' price. Additionally, you may evaluate how the addition of Genetic Signatures to your portfolios can decrease your overall portfolio volatility.